BIOXYTRAN, INC. (BIXT)

Every figure this model derived for BIXT, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2017-12-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 0 PaymentsToAcquirePropertyPlantAndEquipment 2013-09-30
cash 23,448 CashAndCashEquivalentsAtCarryingValue 2017-09-30
current assets 177,384 AssetsCurrent 2026-06-30
current liabilities 5,274,697 LiabilitiesCurrent 2026-06-30
equity -4,941,304 StockholdersEquity 2026-06-30
revenue 191,077 Revenues 2017-12-31
sbc 0 AllocatedShareBasedCompensationExpense 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up BIXT on one particular measure came for.

RatioValue
current ratio0.03
current ratio reported0.03
revenue growth-22.48
revenue growth per share-22.48
sbc pct revenue0.0

What to be careful about

What this model itself distrusts about BIXT's figures. Written by the derivation as it ran, not added afterwards.